Danielle Vrabie

PartnerLitigation and Enforcement Lead, Healthcare Industry Team
LANGUAGES
Russian
LINKEDIN
Vrable Danielle

Overview

Danielle Vrabie defends healthcare and life sciences organizations when government investigations and high-stakes commercial disputes threaten their operations. A seasoned litigator grounded in a deep understanding of how her clients operate and what drives their business, she serves as litigation and enforcement lead for the firm’s Healthcare industry team and co-lead of its False Claims Act team.

Her clients—hospitals and health systems, specialty practice groups, managed care organizations, pharmaceutical and medical device companies, skilled nursing facilities and long-term care providers—rely on her to defend allegations under the False Claims Act and related fraud-and-abuse statutes and to advocate in commercial disputes across state and federal courts and arbitral forums.

On the enforcement side, Danielle conducts internal investigations, navigates whistleblower allegations and defends government inquiries—securing declinations, dismissals and negotiated resolutions. Her deep familiarity with the enforcement landscape allows her to anticipate theories and craft strategies that drive practical outcomes.

Danielle's commercial litigation practice is equally central to her work. She represents clients in healthcare and other highly regulated industries in complex disputes—whether involving allegations of fraud, commercial tort and statutory claims, trade secret and restrictive covenant matters, or class actions.

Across both dimensions of her practice, Danielle draws on an interdisciplinary perspective developed through years of working alongside regulatory, compliance and transactional teams—resolving disputes while safeguarding ongoing operations and long-term business objectives.

A recognized leader, she co-founded the firm’s Women in Healthcare Leadership Collaborative, driving programming and community-building at the intersection of legal, regulatory and innovation issues shaping healthcare's future.

False Claims Act

  • Represented long-term home care provider in FCA suit filed by a former employee alleging that services were provided to patients without proper physician approvals.
  • Defended a national in-home managed care provider in investigation by the DOJ concerning allegations that providers were artificially inflating patients’ RAF scores to increase reimbursement.
  • Represented medical equipment supplier in qui tam suit filed by former employee alleging violations of CMS guidelines governing DME suppliers; district court dismissed all claims pre-discovery. 
  • Defended multiple physician-investors against allegations that their investment in a Intensity-Modulated Radiation Therapy (IMRT) center violated both the Anti-Kickback and Stark Laws.
  • Represented leading aerospace manufacturing company in FCA suit relating to parts certification for airplanes flown by the Department of Defense; district court dismissed all claims pre-discovery and decision was affirmed on appeal.
  • Secured a voluntary dismissal on behalf of medical director defendants in connection with an FCA suit brought by a former employee regarding allegations of upcoding and physician compensation that exceeded the fair market value of the services.  

Internal Investigations & Government Investigations

  • Conducted internal investigation for provider of Chronic Care Management (CCM) services in connection with involving potential FCA exposure related to allegations of improper billing and scope of practice issues.
  • Represented Board of Directors for a large ambulatory surgery center in connection with an investigation of potential FCA exposure related to physician compensation.
  • Successfully resolved New York Attorney General’s investigation into potential overpayments for large managed care organization.
  • Represented several large physician practices in multi-state investigation by the DOJ and HHS Office of Inspector General in connection with clinical laboratory arrangements resulting in non-prosecution.

Complex Commercial Litigation & Arbitration

  • Represented Independent Practice Association (IPA) in an arbitration brought by former physician-members regarding surplus payments received by health plans.  
  • Secured $40 million arbitral award for large international pharmaceutical company in an arbitration related to breaches of investor rights and stockholder purchase agreements by a health system.
  • Represented international distributor of medical devices in an arbitration brought against device manufacturer for breach of contract and breach of warranty claims.
  • Secured complete dismissal on a motion to dismiss for a leading specialty pharmacy in connection with a shareholder derivative action brought by a competitor alleging, among other things, theft of trade secrets.
  • Represented global healthcare company in Federal suit and parallel arbitration proceedings in which former employees sought change-in-control benefits exceeding $15 million.

While in law school, Danielle was named an Alexander Fellow and served as a student judicial clerk to the Honorable Kimba M. Wood, Chief Judge of the U.S. District Court for the Southern District of New York. She also served as a judicial intern to the Honorable Dora L. Irizarry of the U.S. District Court for the Eastern District of New York.
Education

J.D., Benjamin Cardozo Law School, Yeshiva University, 2009

B.S., The College of New Jersey, 2006, magna cum laude

Admissions

New York

U.S. District Court for the Southern and Eastern Districts of New York

U.S. Court of Appeals, Fifth Circuit

Best Lawyers in America: Health Care Law, Best Lawyers, 2026; Notable Woman in Law, Crain's New York Business, 2023; Pro Bono Publico Award, Legal Aid Society, 2013-2015; Bob Williams Award, Sheppard Mullin, 2020.

Speaker, "Understanding the Legal Landscape: Government Enforcement Trends," 2024 WHLC Women in Healthcare Leadership Summit, October 24, 2024

Speaker, “A Contract is a Contract – or Is It?” myLawCLE, June 4, 2024

Speaker, "Managed Care False Claims Act Risk," American Bar Association (“ABA”) Managed Care Institute, December 14, 2022 

Speaker, "Impact of Chart Reviews and HRAs on MA Payments: The OIG's Findings and the Landscape Ahead," American Health Law Association, April 14, 2022

Speaker, "Fraud and Abuse & Managed Care: Key Issues and 2021 Updates," American Health Law Association, November 4, 2021

Moderator, "Ethically Handling FCA Investigations, Litigation, and Whistleblowers," False Claims Act and Qui Tam Trial Institute 2019, June 19, 2019

  • Co-author of the “Health Care Fraud and Abuse 2016 Update” chapter in Health Law Handbook, Twenty-Ninth Edition (2017), WestGroup, a Thomson Company.
  • Co-author of the “Excuses Doctrine” chapter in Commercial Contracts: Strategies for Drafting and Negotiating, Second Edition (2015), Wolters Kluwer.